ProPublica. May 3, 2012. “And after being notified of patient harm, manufacturers can minimize their own responsibility if they point the blame elsewhere,” said health policy expert Diana Zuckerman, president of the Cancer Prevention and Treatment Fund and the National Research Center for Women & Families.
Dr. Diana Zuckerman is quoted in the Consumer Reports investigation for their May issue that finds that most medical implants have never been tested for safety.
AP News January 5, 2012 on NRC’s letter to Dr. Margaret Hamburg, FDA Commissioner, on the missing data for breast implants.
Reuters, December 29, 2011. With the scandal surrounding France’s Poly Implant Prothese (PIP), questions arise whether there should be a national or worldwide breast implant registry.
Washington Post. November 19, 2011. “The science is clear: Breast cancer patients are more likely to be harmed than helped by Avastin,” said Diana Zuckerman, president of the National Research Center for Women & Families. “The risks of the drug are very substantial and can be fatal, killing patients long before they would otherwise die from the disease. FDA made a scientific decision, and it was absolutely the right decision.”
NRC President, Dr. Diana Zuckerman, tells AP about the problems with Avastin.